COST-EFFECTIVENESS ANALYSIS OF REMDESIVIR FOR THE TREATMENT OF COVID-19 HOSPITALIZED ADULTS IN MEXICO

被引：0
|
作者：
Ponce-de-Leon, A. [1 ]
Azamar-Alonso, A. [2 ]
Silva-Sanchez, F. [2 ]
Chirino-Sprung, R. [2 ]
Dominguez-Esquivel, V [3 ]
Rajme-Lopez, S. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[2] Gilead Sci Mexico S RL CV, Mexico City, DF, Mexico
[3] HS Estudios Farmacoeconom, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC41
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness analysis of COVID-19 vaccination in Poland
    Orlewska, Katarzyna
    Wierzba, Waldemar
    Sliwczynski, Andrzej
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (04) : 1021 - 1030
  • [22] Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
    Murton, Molly
    Drane, Emma
    Jarrett, James
    Cornely, Oliver A.
    Soriano, Alex
    INFECTION, 2023, 51 (02) : 285 - 303
  • [23] Remdesivir in hospitalized COVID-19 Patients
    Thiem, Helena
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (03): : 111 - +
  • [24] A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States
    Daniel Sheinson
    Joseph Dang
    Anuj Shah
    Yang Meng
    David Elsea
    Stacey Kowal
    Advances in Therapy, 2021, 38 : 1811 - 1831
  • [25] A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States
    Sheinson, Daniel
    Dang, Joseph
    Shah, Anuj
    Meng, Yang
    Elsea, David
    Kowal, Stacey
    ADVANCES IN THERAPY, 2021, 38 (04) : 1811 - 1831
  • [26] Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
    Ergun Oksuz
    Simten Malhan
    Mustafa Sait Gonen
    Zekayi Kutlubay
    Yilmaz Keskindemirci
    James Jarrett
    Toros Sahin
    Gokcem Ozcagli
    Ahmet Bilgic
    Merve Ozlem Bibilik
    Fehmi Tabak
    Advances in Therapy, 2021, 38 : 4935 - 4948
  • [27] Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
    Oksuz, Ergun
    Malhan, Simten
    Gonen, Mustafa Sait
    Kutlubay, Zekayi
    Keskindemirci, Yilmaz
    Jarrett, James
    Sahin, Toros
    Ozcagli, Gokcem
    Bilgic, Ahmet
    Bibilik, Merve Ozlem
    Tabak, Fehmi
    ADVANCES IN THERAPY, 2021, 38 (09) : 4935 - 4948
  • [28] Cost-effectiveness Analysis and Impact on Length of Hospital Stay of the Introduction of Remdesivir as a Treatment Option for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen in Greece Versus Standard of Care
    Athanasakis, Kostas
    Zisis, Konstantinos
    Tsoulas, Christos
    Nomikos, Nikolaos
    CLINICAL THERAPEUTICS, 2023, 45 (12) : 1244 - 1250
  • [29] Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation
    Breskin, Alexander
    Wiener, Catherine
    Adimora, Adaora A.
    Brown Jr, Robert S.
    Landis, Charles
    Reddy, K. Rajender
    Verna, Elizabeth C.
    Crawford, Julie M.
    Mospan, Andrea
    Fried, Michael W.
    Brookhart, M. Alan
    EPIDEMIOLOGY, 2023, 34 (03) : 365 - 375
  • [30] Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US
    Hardik Goswami
    Adnan Alsumali
    Yiling Jiang
    Matthias Schindler
    Elizabeth R. Duke
    Joshua Cohen
    Andrew Briggs
    Amy Puenpatom
    PharmacoEconomics, 2022, 40 : 699 - 714
12345